Citation Impact
Citing Papers
Clinical Practice Guidelines for the Diagnosis and Management of Intravascular Catheter-Related Infection: 2009 Update by the Infectious Diseases Society of America
2009 Standout
Removing T-cell epitopes with computational protein design
2014 StandoutNobel
Clinical Practice Guidelines for the Management Candidiasis: 2009 Update by the Infectious Diseases Society of America
2009 Standout
Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
2009 Standout
Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem
2007 Standout
Therapy-Related Cardiac Risk in Childhood Cancer Survivors: An Analysis of the Childhood Cancer Survivor Study
2019
A systematic approach to identify novel cancer drug targets using machine learning, inhibitor design and high-throughput screening
2014
Antimicrobial therapy for patients with severe sepsis and septic shock: An evidence-based review
2004
Engineering precision nanoparticles for drug delivery
2020 Standout
Ischemia and reperfusion—from mechanism to translation
2011 Standout
Chimeric Antigen Receptor–Modified T Cells for Acute Lymphoid Leukemia
2013 Standout
Siglecs and their roles in the immune system
2007 Standout
The Clinical Sequelae of Intravascular Hemolysis and Extracellular Plasma Hemoglobin
2005 Standout
Prevention of catheter-related bloodstream infections: analysis of studies published between 2002 and 2005
2006
Cell cycle proteins as promising targets in cancer therapy
2017 Standout
DNA‐Coated AFM Cantilevers for the Investigation of Cell Adhesion and the Patterning of Live Cells
2008 StandoutNobel
Secondary leukemias induced by topoisomerase-targeted drugs
1998
Antimicrobial therapy of unexplained fever in neutropenic patients
2003
BK Virus: Opportunity Makes a Pathogen
2005
Oral Cefixime Is Similar to Continued Intravenous Antibiotics in the Empirical Treatment of Febrile Neutropenic Children with Cancer
2001
Systematic review of natural agents for the management of oral mucositis in cancer patients
2013
Lipid-based amphotericin B: a review of the last 10 years of use
2001
Amphotericin B Nephrotoxicity in Children
2004
Targeting iNKT cells for the treatment of sickle cell disease
2011
CRISPR-Cas9 screens identify regulators of antibody–drug conjugate toxicity
2019 StandoutNobel
Identification of synthetic lethality of PLK1 inhibition and microtubule-destabilizing drugs
2015
Survivors of childhood and adolescent cancer: life-long risks and responsibilities
2013 Standout
Severe Sepsis and Septic Shock
2013 Standout
Treatment of 21 Cases of Invasive Mucormycosis with Amphotericin B Colloidal Dispersion
2001
Predictors of outcome following myeloablative allo-SCT for therapy-related myelodysplastic syndrome and AML
2008
Nano based drug delivery systems: recent developments and future prospects
2018 Standout
Acute leukemia as a secondary malignancy in children and adolescents: Current findings and issues
2008
Epidemiology and Outcome of Zygomycosis: A Review of 929 Reported Cases
2005 Standout
Liposomal amphotericin B: clinical experience and perspectives
2005
Bacterial biofilms: from the Natural environment to infectious diseases
2004 Standout
PEGylation as a strategy for improving nanoparticle-based drug and gene delivery
2015 Standout
Chronic Health Conditions in Adult Survivors of Childhood Cancer
2006 Standout
Salvage Therapy for Refractory or Relapsed Acute Lymphocytic Leukemia
2001
Echinocandin antifungal drugs
2003 Standout
A Double‐Blind, Randomized, Controlled Trial of Amphotericin B Colloidal Dispersion versus Amphotericin B for Treatment of Invasive Aspergillosis in Immunocompromised Patients
2002
Updated Clinical Classification of Pulmonary Hypertension
2013 Standout
Short Courses of Intravenous Empirical Antibiotic Treatment in Selected Febrile Neutropenic Children with Cancer
2002
Sickle-cell disease
2010 Standout
A multicenter, randomized trial of fluconazole versus amphotericin B for empiric antifungal therapy of febrile neutropenic patients with cancer
2000
Time to Initiation of Fluconazole Therapy Impacts Mortality in Patients with Candidemia: A Multi‐Institutional Study
2006 Standout
A Randomized, Double-Blind Comparative Trial Evaluating the Safety of Liposomal Amphotericin B versus Amphotericin B Lipid Complex in the Empirical Treatment of Febrile Neutropenia
2000
Nanomaterial-based therapeutics for antibiotic-resistant bacterial infections
2020 Standout
Efficacy and safety of micafungin for treatment of serious Candida infections in patients with or without malignant disease
2011
Nanopharmaceuticals (part 1): products on the market
2014
Applications of machine learning in drug discovery and development
2019 Standout
Mycoses in Pediatric Patients
2006
Antifungal Agents in Children
2005
Targeting DNA topoisomerase II in cancer chemotherapy
2009 Standout
Relevance of historical therapeutic approaches to the contemporary treatment of pediatric solid tumors
2013
MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy
2020 Standout
Liposomal drug delivery systems: From concept to clinical applications
2012 Standout
Guidelines for the Prevention of Intravascular Catheter-related Infections
2011 Standout
Activity of micafungin (FK463) against an itraconazole-resistant strain of Aspergillus fumigatus and a strain of Aspergillus terreus demonstrating in vivo resistance to amphotericin B
2003
Second Malignant Neoplasms in Five-Year Survivors of Childhood Cancer: Childhood Cancer Survivor Study
2001
Glutamine-Enriched Nutrition Does Not Reduce Mucosal Morbidity or Complications After Stem-Cell Transplantation for Childhood Malignancies: A Prospective Randomized Study
2011
Direct Detection of Bacterial Biofilms on the Middle-Ear Mucosa of Children With Chronic Otitis Media
2006 Standout
Siglecs—the major subfamily of I-type lectins
2005
Pulmonary Complications of Sickle Cell Disease
2012
Arginine Therapy
2003
Practice Guidelines for the Diagnosis and Management of Skin and Soft Tissue Infections: 2014 Update by the Infectious Diseases Society of America
2014 Standout
Acinetobacter baumannii : Emergence of a Successful Pathogen
2008 Standout
Magnesium in Man: Implications for Health and Disease
2014 Standout
Prevention and Treatment of Cancer-Related Infections
2012
Homing and immunogenicity of murine stromal cells transfected with xenogeneic MHC class II genes
1995
Therapeutic Benefit of Intravenous Administration of Bone Marrow Stromal Cells After Cerebral Ischemia in Rats
2001 Standout
Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America
2011 Standout
Cytoagglutination and cytotoxicity of Wheat Germ Agglutinin isolectins against normal lymphocytes and cultured leukemic cell lines—relationship between structure and biological activity
2003
Invasive Candidiasis
2015 Standout
Amphotericin B nephrotoxicity
2002
2002 Guidelines for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer
2002 Standout
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
2016 Standout
Diagnosis, Prevention, and Treatment of Catheter-Associated Urinary Tract Infection in Adults: 2009 International Clinical Practice Guidelines from the Infectious Diseases Society of America
2010 Standout
Pharmacology of Systemic Antifungal Agents
2006
Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America
2015 Standout
Treatment of Hematologic Malignancies with Immunotoxins and Antibody-Drug Conjugates
2011
The B Cell Coreceptor CD22 Associates with AP50, a Clathrin-Coated Pit Adapter Protein, Via Tyrosine-Dependent Interaction
2003
Intravenous and Oral Itraconazole versus Intravenous Amphotericin B Deoxycholate as Empirical Antifungal Therapy for Persistent Fever in Neutropenic Patients with Cancer Who Are Receiving Broad-Spectrum Antibacterial Therapy
2001
Current issues in chronic graft-versus-host disease
2014
Cancer treatment and survivorship statistics, 2019
2019 Standout
Cell surface sialic acids do not affect primary CD22 interactions with CD45 and surface IgM nor the rate of constitutive CD22 endocytosis
2004
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
Treatment of Aspergillosis: Clinical Practice Guidelines of the Infectious Diseases Society of America
2008 Standout
Bacterial biofilms: a diagnostic and therapeutic challenge
2003
Investigational nanomedicines in 2016: a review of nanotherapeutics currently undergoing clinical trials
2016
Executive Summary: Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America
2016 Standout
Analysis of nanoparticle delivery to tumours
2016 Standout
Guidelines for Treatment of Candidiasis
2004 Standout
Rapid Hematopoietic Recovery After Coinfusion of Autologous-Blood Stem Cells and Culture-Expanded Marrow Mesenchymal Stem Cells in Advanced Breast Cancer Patients Receiving High-Dose Chemotherapy
2000 Standout
Reactive oxygen species generating systems meeting challenges of photodynamic cancer therapy
2016 Standout
Clinical Translation of Nanomedicine
2015
Therapeutic approach to Candida sepsis
1999
Invasive fungal infections: a review of epidemiology and management options
2006
Works of Eric Sandler being referenced
A double-blind randomized placebo-controlled study of oral glutamine in the prevention of mucositis in children undergoing hematopoietic stem cell transplantation: a pediatric blood and marrow transplant consortium study
2005
Efficacy of ifosfamide and doxorubicin given as a phase II “window” in children with newly diagnosed metastatic rhabdomyosarcoma: A report from the Intergroup Rhabdomyosarcoma Study Group*
2001
Randomized, Double‐Blind Clinical Trial of Amphotericin B Colloidal Dispersion vs. Amphotericin B in the Empirical Treatment of Fever and Neutropenia
1998
Effective Dose Reduction to Cardiac Structures Using Protons Compared With 3DCRT and IMRT in Mediastinal Hodgkin Lymphoma
2012
Use of Amphotericin B Colloidal Dispersion in Children
2000
Treatment of children with epipodophyllotoxin-induced secondary acute myeloid leukemia
1997
Effect of Oral Arginine Supplementation on Exhaled Nitric Oxide Concentration in Sickle Cell Anemia and Acute Chest Syndrome
2010
BK papova virus pneumonia following hematopoietic stem cell transplantation
1997
Hematopoietic Stem Cell Transplantation After First Marrow Relapse of Non-T, Non-B Acute Lymphoblastic Leukemia
2006
A Phase 1 Study of Combotox in Pediatric Patients With Refractory B-lineage Acute Lymphoblastic Leukemia
2009
Immunotoxins against CD19 and CD22 are effective in killing precursor-B acute lymphoblastic leukemia cells in vitro
2000
Treatment of children and adolescents with localized parameningeal sarcoma: Experience of the Intergroup Rhabdomyosarcoma Study Group protocols IRS‐II through ‐IV, 1978–1997*†
2001
A Prospective Double-Blind Randomized Trial of Urokinase Flushes to Prevent Bacteremia Resulting From Luminal Colonization of Subcutaneous Central Venous Catheters
2002
Low Exhaled Nitric Oxide and a Polymorphism in the NOS I Gene Is Associated with Acute Chest Syndrome
2001
Hematopoietic growth factor induction of gamma-glutamyl transferase in the KG-1 myeloid cell line.
1993
Randomized Trial of Hydroxychloroquine for Newly Diagnosed Chronic Graft-versus-Host Disease in Children: A Children’s Oncology Group Study
2011
Feasibility of oral ciprofloxacin for the outpatient management of febrile neutropenia in selected children with cancer
2000
Beneficial Effect of Intravenous Dexamethasone in Children With Mild to Moderately Severe Acute Chest Syndrome Complicating Sickle Cell Disease
1998